According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996.HK) announced that the Group is expected to earn revenue of between RMB 490 million and $536 million for the six months ending June 30, 2026, and approximately RMB 53.2 million in the six months ending June 30, 2025; the profit earned during the period ranged from RMB 195 million to RMB 238 million, and a loss of approximately RMB 76.4 million during the corresponding period.

According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996.HK) announced that the Group is expected to earn revenue of between RMB 490 million and $536 million for the six months ending June 30, 2026, and approximately RMB 53.2 million in the six months ending June 30, 2025; the profit earned during the period ranged from RMB 195 million to RMB 238 million, and a loss of approximately RMB 76.4 million during the corresponding period.